These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 26327684)

  • 21. Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Abeta peptides and promotes cerebrovascular amyloid angiopathy.
    Clifford PM; Siu G; Kosciuk M; Levin EC; Venkataraman V; D'Andrea MR; Nagele RG
    Brain Res; 2008 Oct; 1234():158-71. PubMed ID: 18708033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development of cerebral amyloid angiopathy in cerebral vessels. A review with illustrations based upon own investigated post mortem cases.
    Mendel TA; Wierzba-Bobrowicz T; Lewandowska E; Stępień T; Szpak GM
    Pol J Pathol; 2013 Dec; 64(4):260-7. PubMed ID: 24375040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways.
    Albargothy NJ; Johnston DA; MacGregor-Sharp M; Weller RO; Verma A; Hawkes CA; Carare RO
    Acta Neuropathol; 2018 Jul; 136(1):139-152. PubMed ID: 29754206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy.
    Inoue Y; Ueda M; Tasaki M; Takeshima A; Nagatoshi A; Masuda T; Misumi Y; Kosaka T; Nomura T; Mizukami M; Matsumoto S; Yamashita T; Takahashi H; Kakita A; Ando Y
    Acta Neuropathol; 2017 Oct; 134(4):605-617. PubMed ID: 28478503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.
    Weller RO; Boche D; Nicoll JA
    Acta Neuropathol; 2009 Jul; 118(1):87-102. PubMed ID: 19234858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease.
    Roher AE; Kuo YM; Esh C; Knebel C; Weiss N; Kalback W; Luehrs DC; Childress JL; Beach TG; Weller RO; Kokjohn TA
    Mol Med; 2003; 9(3-4):112-22. PubMed ID: 12865947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease.
    Allen N; Robinson AC; Snowden J; Davidson YS; Mann DM
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):136-48. PubMed ID: 23808763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele.
    Hawkes CA; Sullivan PM; Hands S; Weller RO; Nicoll JA; Carare RO
    PLoS One; 2012; 7(7):e41636. PubMed ID: 22848551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
    Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
    Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
    Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
    Merlini M; Wanner D; Nitsch RM
    Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J; Jellinger KA; Lintner F
    Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy.
    Owasil R; O'Neill R; Keable A; Nimmo J; MacGregor Sharp M; Kelly L; Saito S; Simpson JE; Weller RO; Smith C; Attems J; Wharton SB; Yuen HM; Carare RO
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy.
    Zabel M; Schrag M; Crofton A; Tung S; Beaufond P; Van Ornam J; Dininni A; Vinters HV; Coppola G; Kirsch WM
    Brain Pathol; 2013 Jul; 23(4):390-401. PubMed ID: 23134465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice.
    Merlini M; Meyer EP; Ulmann-Schuler A; Nitsch RM
    Acta Neuropathol; 2011 Sep; 122(3):293-311. PubMed ID: 21688176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.
    Greenberg SM; Bacskai BJ; Hernandez-Guillamon M; Pruzin J; Sperling R; van Veluw SJ
    Nat Rev Neurol; 2020 Jan; 16(1):30-42. PubMed ID: 31827267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue transglutaminase: a novel therapeutic target in cerebral amyloid angiopathy.
    Wilhelmus MM; de Jager M; Drukarch B
    Neurodegener Dis; 2012; 10(1-4):317-9. PubMed ID: 22156619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.